The results indicated that PRMT5 overexpression rescued ferroptosis in ACSL4-WT RCC cells but had minimal effect on cell viability in ACSL4-R549K cells (Fig. 5A and B and Fig. S5A and B). Here, PRMT5 is linked to renal cell carcinoma.